Oprozomib (ONX 0912) , an inhibitor for CT-L activity of 20S proteasome β5（IC50=36 nM）/LMP7（IC50=82 nM）, is orally bioavailable. Oprozomib also has potential antineoplastic activity.
More Information Supplier Page
[11C]MP 10, a specific and effective PDE10A inhibitor (IC50=0.37 nM), is with more than1000-fold specificity activity over the PDE.
More Information Supplier Page
[11C]MP 10, a specific and effective PDE10A inhibitor (IC50=0.37 nM), is with more than1000-fold specificity activity over the PDE.
More Information Supplier Page 
Ledipasvir (acetone) is an HCV NS5A polymerase inhibitor, used for the treatment of hepatitis C virus infection.
More Information Supplier Page
Ledipasvir (acetone) is an HCV NS5A polymerase inhibitor, used for the treatment of hepatitis C virus infection.
More Information Supplier Page 
TD-198946, a potent chondrogenic agent, is a thienoindazole derivative.
More Information Supplier Page
TD-198946, a potent chondrogenic agent, is a thienoindazole derivative.
More Information Supplier Page 
Hnps-PLA Inhibitor is an inhibitor of human nonpancreatic secretory Phospholipase A (hnps-PLA).
More Information Supplier Page
Hnps-PLA Inhibitor is an inhibitor of human nonpancreatic secretory Phospholipase A (hnps-PLA).
More Information Supplier Page Hnps-PLA Inhibitor is an inhibitor of human nonpancreatic secretory Phospholipase A (hnps-PLA).
More Information Supplier Page 
